Phase IB study on combined intradermal (ID) and intravenous (IV) administration of autologous mRNA electroporated dendritic cells (DC) as a single-agent cellular immunotherapy or combined with ipilimumab.

Bart Neyns; Sofie Wilgenhof; An Van Nuffel; Daphné Benteyn; Jurgen Corthals; Carlo Heirman; Joeri Aerts; Ivan Van Riet; Aude Bonehill; Kris Thielemans

Phase IB study on combined intradermal (ID) and intravenous (IV) administration of autologous mRNA electroporated dendritic cells (DC) as a single-agent cellular immunotherapy or combined with ipilimumab.

Bart Neyns, Sofie Wilgenhof, An Van Nuffel, Daphné Benteyn, Jurgen Corthals, Carlo Heirman, Joeri Aerts, Ivan Van Riet, Aude Bonehill, Kris Thielemans

Research output: Chapter in Book/Report/Conference proceeding › Meeting abstract (Book)

Original language	English
Title of host publication	American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, USA
Publication status	Published - Jun 2012

Keywords

dendritic cells
mRNA
immunotherapy
ipilimumab

Cite this

Neyns, B., Wilgenhof, S., Van Nuffel, A., Benteyn, D., Corthals, J., Heirman, C., Aerts, J., Van Riet, I., Bonehill, A., & Thielemans, K. (2012). Phase IB study on combined intradermal (ID) and intravenous (IV) administration of autologous mRNA electroporated dendritic cells (DC) as a single-agent cellular immunotherapy or combined with ipilimumab. In American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, USA

@inbook{33ff5490ea5a4242ae33faedec3c4bac,

title = "Phase IB study on combined intradermal (ID) and intravenous (IV) administration of autologous mRNA electroporated dendritic cells (DC) as a single-agent cellular immunotherapy or combined with ipilimumab.",

keywords = "dendritic cells, mRNA, immunotherapy, ipilimumab",

author = "Bart Neyns and Sofie Wilgenhof and {Van Nuffel}, An and Daphn{\'e} Benteyn and Jurgen Corthals and Carlo Heirman and Joeri Aerts and {Van Riet}, Ivan and Aude Bonehill and Kris Thielemans",

year = "2012",

month = jun,

language = "English",

booktitle = "American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, USA",

}

Neyns, B, Wilgenhof, S, Van Nuffel, A, Benteyn, D, Corthals, J, Heirman, C, Aerts, J , Van Riet, I, Bonehill, A & Thielemans, K 2012, Phase IB study on combined intradermal (ID) and intravenous (IV) administration of autologous mRNA electroporated dendritic cells (DC) as a single-agent cellular immunotherapy or combined with ipilimumab. in American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, USA.

Phase IB study on combined intradermal (ID) and intravenous (IV) administration of autologous mRNA electroporated dendritic cells (DC) as a single-agent cellular immunotherapy or combined with ipilimumab. / Neyns, Bart; Wilgenhof, Sofie; Van Nuffel, An et al.
American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, USA. 2012.

Research output: Chapter in Book/Report/Conference proceeding › Meeting abstract (Book)

TY - CHAP

T1 - Phase IB study on combined intradermal (ID) and intravenous (IV) administration of autologous mRNA electroporated dendritic cells (DC) as a single-agent cellular immunotherapy or combined with ipilimumab.

AU - Neyns, Bart

AU - Wilgenhof, Sofie

AU - Van Nuffel, An

AU - Benteyn, Daphné

AU - Corthals, Jurgen

AU - Heirman, Carlo

AU - Aerts, Joeri

AU - Van Riet, Ivan

AU - Bonehill, Aude

AU - Thielemans, Kris

PY - 2012/6

Y1 - 2012/6

KW - dendritic cells

KW - mRNA

KW - immunotherapy

KW - ipilimumab

M3 - Meeting abstract (Book)

BT - American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, USA

ER -